Displaying 1 to 5 of 5 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. |
United States | 3 May 2006 | Acquisition 150,000,000 (USD 150,000,000) deal size. |
|
|
|
GlobeImmune Inc Biopharmaceuticals company. |
United States | N/A |
||
|
|
Intellikine |
United States | 1 Jul 2009 | Series B Active |
|
|
|
Portola Pharmaceuticals Inc |
United States | N/A Active |
||
|
|
Syntonix Pharmaceuticals Inc A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into |
United States | 4 Jan 2007 | Acquisition |